These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 2447540)

  • 21. Detection of neural tube defects with alpha-fetoprotein measurement in amniotic fluid. A protocol for managing elevated values.
    Wilson GN; Raj A; Waterson JR; Bush M; Baty E; Parker J; Hamman J; Louwsma G; Barr M
    J Reprod Med; 1986 Mar; 31(3):157-61. PubMed ID: 2422375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
    Needleman SB; Goldstein AI; Johnson AM; Golubjatnikov R; Ward AM; Fifield R
    J Reprod Med; 1980 Sep; 25(3):101-7. PubMed ID: 6159471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive amniotic fluid acetylcholinesterase results: the need for a multifacet approach to the prenatal diagnosis of neural tube defects.
    Lee JE; Ng WG; Falk RE; Alfi O; Lopez L; Platt LD
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):22S-24S. PubMed ID: 2410841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems in prenatal diagnosis of neural tube defects (author's transl)].
    Leucht W; Müller E; Heyes H; Töllner U; Jonatha W
    Z Geburtshilfe Perinatol; 1979 Dec; 183(6):434-7. PubMed ID: 94962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of alpha-fetoprotein, cholinesterase and alpha 2-macroglobulin in the amniotic fluid in the diagnosis of neural tube defects].
    Lamedica G; Parodi E; Rossi G; Ambrosini L; Porro E
    Ann Ostet Ginecol Med Perinat; 1983; 104(4):261-9. PubMed ID: 6197921
    [No Abstract]   [Full Text] [Related]  

  • 26. Prenatal diagnosis of neural tube defects through amniotic fluid measurements.
    Brock DJ
    UCLA Forum Med Sci; 1978; 20():154-62. PubMed ID: 80856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contribution of amniocentesis to prenatal screening of neural tube closing defects: evaluation of 10 years of a center's experience].
    Guibaud S; Capella-Bonnet M; Simplot A
    J Genet Hum; 1985 Sep; 33(3-4):339-45. PubMed ID: 2414399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prenatal diagnosis of congenital defects through the determination of alpha fetoprotein].
    Weitzel HK; Schumann K; Schneider J
    Fortschr Med; 1979 Jun; 97(21):1005-8. PubMed ID: 86490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
    Kirkpatrick A; Cohen M; Prescott GH; Jones OW; Matson M; Wepsic HT
    UCLA Forum Med Sci; 1978; 20():199-205. PubMed ID: 80862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA; Pettenati MJ; Burton BK
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of ultrasound and informed consent in the evaluation of elevated maternal serum alpha-fetoprotein.
    Katz VL; Seeds JW; Albright SG; Lingley LH; Lincoln-Boyea B
    Am J Perinatol; 1991 Mar; 8(2):73-6. PubMed ID: 1706599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prenatal recognition of genetic diseases and neural tube defects].
    Fuhrmann W
    Geburtshilfe Frauenheilkd; 1983 Jun; 43(6):399-404. PubMed ID: 6193031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Unusual increase in amniotic fluid alpha fetoprotein and trisomy 13].
    Guibaud S; Pison H; Simplot A; Boisson C; Germain D
    J Genet Hum; 1987 Aug; 35(4):237-41. PubMed ID: 2443615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
    Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP
    AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
    Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
    J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prenatal diagnosis of neural tube and abdominal wall defects in the 2d trimester].
    Mühlhaus K; Weitzel HK; Schneider J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):98-100. PubMed ID: 2579872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.